.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Acute kidney injury (AKI) frequently occurs in patients receiving anti-PD-L1 immunotherapy. This clinical observation suggests that PD-L1 maintains renal homeostasis. However, the exact mechanism remained unknown until now. A groundbreaking study recently identified a T-cell independent role for PD-L1 in AKI repair. Specifically, the research focuses on how PD-L1 interacts with the BRCA1 protein to safeguard tubular epithelial cells (TECs).
The study found that PD-L1 is primarily expressed in the proximal tubules. Both murine models and human renal biopsies showed a significant upregulation of PD-L1 following injury. When researchers deleted PD-L1 in mouse TECs, renal injury worsened after ischemia-reperfusion. Mechanistically, PD-L1 binds to BRCA1 and increases its expression. Furthermore, this interaction protects the cells against DNA damage. Consequently, the kidney promotes cellular proliferation and suppresses apoptosis to facilitate repair.
To translate these findings, the team developed a CGA-functionalized extracellular vesicle delivery system. This platform provides targeted delivery of PD-L1 specifically to injured TECs. Additionally, the system effectively restored PD-L1 levels in both PD-L1 knockdown and T-cell knockout mouse models. Thus, PD-L1 supplementation represents a promising therapeutic strategy for treating AKI. Moreover, this pathway operates independently of the canonical immunomodulatory functions associated with T cells.
PD-L1 interacts with BRCA1 to enhance its expression in tubular epithelial cells. This process mitigates DNA damage, which encourages cell survival and promotes the proliferation needed for tissue repair.
No, researchers discovered that this specific repair mechanism is T-cell independent. It focuses on the internal stability and DNA repair capacity of the tubular cells themselves rather than immune signaling.
Disclaimer: This content is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Researchers discover a T-cell independent role for PD-L1 in kidney repair by interacting with BRCA1 to reduce DNA damage and promote cell survival....
4 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
